Min Woo Kim

Min Woo Kim

Auto-generated profile, based on publicly available information

Min Woo Kim

Brain Immunology and Glia (BIG) Center, Washington University in St. Louis, St. Louis, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2024 in Nature
Verified
Journal Article
Closed access
PDF file
LSLeon Smyth
Leon Smyth
DXDi Xu
Di Xu
SOSerhat V. Okar
Serhat V. Okar
TDTaitea Dykstra
Taitea Dykstra
JRJustin Rustenhoven
Justin Rustenhoven
JKJonathan Kipnis
Jonathan Kipnis

30 November 2017 in eLife
Verified
Journal Article
Open access
MKMin Woo Kim
Min Woo Kim
WWWenjing Wang
Wenjing Wang
MSMateo I Sanchez
Mateo I Sanchez
RCRobert Coukos
Robert Coukos
MZMark von Zastrow
Mark von Zastrow
ATAlice Y Ting
Alice Y Ting
Transcriptional assays, such as yeast two-hybrid and TANGO, that convert transient protein-protein interactions (PPIs) into stable expression of transgenes are powerful tools for PPI discovery, screens, and analysis of cell populations. However, such assays often have high background and lose information about PPI dynamics. We have developed SPARK (Specific Protein Association tool giving transcriptional Readout with rapid Kinetics), in which proteolytic release of a membrane-tethered transcription factor (TF) requires both a PPI to deliver a protease proximal to its cleavage peptide and blue light to uncage the cleavage site. SPARK was used to detect 12 different PPIs in mammalian cells, with 5 min temporal resolution and signal ratios up to 37. By shifting the light window, we could reconstruct PPI time-courses. Combined with FACS, SPARK enabled 51 fold enrichment of PPI-positive over PPI-negative cells. Due to its high specificity and sensitivity, SPARK has the potential to advance PPI analysis and discovery.

3 April 2019 in eLife
Verified
Journal Article
Open access
CKChristina K Kim
Christina K Kim
KCKelvin F Cho
Kelvin F Cho
MKMin Woo Kim
Min Woo Kim
ATAlice Y Ting
Alice Y Ting
Technologies that convert transient protein-protein interactions (PPIs) into stable expression of a reporter gene are useful for genetic selections, high-throughput screening, and multiplexing with omics technologies. We previously reported SPARK (Kim et al., 2017), a transcription factor that is activated by the coincidence of blue light and a PPI. Here, we report an improved, second-generation SPARK2 that incorporates a luciferase moiety to control the light-sensitive LOV domain. SPARK2 can be temporally gated by either external light or addition of a small-molecule luciferin, which causes luciferase to open LOV via proximity-dependent BRET. Furthermore, the nested ‘AND’ gate design of SPARK2—in which both protease recruitment to the membrane-anchored transcription factor and LOV domain opening are regulated by the PPI of interest—yields a lower-background system and improved PPI specificity. We apply SPARK2 to high-throughput screening for GPCR agonists and for the detection of trans-cellular contacts, all with versatile transcriptional readout.

4 September 2024 in Nature
Verified
Journal Article
Closed access
PDF file
WGWenqing Gao
Wenqing Gao
MKMin Woo Kim
Min Woo Kim
TDTaitea Dykstra
Taitea Dykstra
SDSiling Du
Siling Du
PBPavle Boskovic
Pavle Boskovic
JKJonathan Kipnis
Jonathan Kipnis

30 October 2024 in Nature
Verified
Journal Article
Open access
PDF file
MKMin Woo Kim
Min Woo Kim
WGWenqing Gao
Wenqing Gao
CLCheryl Lichti
Cheryl Lichti
XGXingxing Gu
Xingxing Gu
TDTaitea Dykstra
Taitea Dykstra
JKJonathan Kipnis
Jonathan Kipnis
Despite the presence of strategically positioned anatomical barriers designed to protect the central nervous system (CNS), it is not entirely isolated from the immune system1,2. In fact, it remains physically connected to, and can be influenced by, the peripheral immune system1. How the CNS retains such responsiveness while maintaining an immunologically unique status remains an outstanding question. Here, in searching for molecular cues that derive from the CNS and enable its direct communication with the immune system, we identified an endogenous repertoire of CNS-derived regulatory self-peptides presented on major histocompatibility complex class II (MHC-II) molecules in the CNS and at its borders. During homeostasis, these regulatory self-peptides were found to be bound to MHC-II molecules throughout the path of lymphatic drainage from the brain to its surrounding meninges and its draining cervical lymph nodes. However, in neuroinflammatory disease, the presentation of regulatory self-peptides diminished. After boosting the presentation of these regulatory self-peptides, a population of suppressor CD4+ T cells was expanded, controlling CNS autoimmunity in a CTLA-4- and TGFβ-dependent manner. CNS-derived regulatory self-peptides may be the molecular key to ensuring a continuous dialogue between the CNS and the immune system while balancing overt autoreactivity. This sheds light on how we conceptually think about and therapeutically target neuroinflammatory and neurodegenerative diseases.

9 June 2025 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
BPBenjamin A. Plog
Benjamin A. Plog
KKKyungdeok Kim
Kyungdeok Kim
DVDaan Verhaege
Daan Verhaege
MKMin Woo Kim
Min Woo Kim
ZPZachary Papadopoulos
Zachary Papadopoulos
ADAntoine Drieu
Antoine Drieu